Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Therapy for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
- Status
- TERMINATED
- Phase
- NA
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
RAD001 Plus Carboplatin in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
- Status
- COMPLETED
- Phase
- PHASE3
Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2